Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis Szinnai G; Meier C; Komminoth P; Zumsteg UWPediatrics 2003[Feb]; 111 (2): E132-9OBJECTIVES: The aim of this study was first to investigate whether early total thyroidectomy (ETT; 1-5 years of age) can prevent medullary thyroid carcinoma with persistent or recurrent disease (PRD) in pediatric patients with multiple endocrine neoplasia type 2A (MEN-2A) and second, to evaluate the strength of codon analysis in children with MEN-2A as prognostic parameter. METHODS: Case reports and review of the literature for pediatric patients with MEN-2A were conducted. Inclusion criteria were age (0-20 years) and histologic degree of C-cell disease (normal = N, C-cell hyperplasia = CCH, medullary thyroid carcinoma = MTC, metastatic MTC = MMTC). To evaluate therapeutic results of ETT (1-5 years) versus late total thyroidectomy (LTT; 6-20 years), age-dependent histologic stages of C-cell disease and postoperative occurrence of PRD were compared. Prognostic value of specific codons, age-dependent histologic distribution, and long-term outcome were analyzed. RESULTS: In a total of 260 cases, 42 (16%) underwent ETT, and 218 (84%) underwent LTT. Histologic analysis showed significant difference between ETT versus LTT (57% vs 76%) regarding malignant stage of C-cell disease (of combined rate of MTC and MMTC). Long-term outcome was documented in 74 patients (28%). During a median follow-up period of 2 years (range: 0-15 years), 21 of 65 of the LTT group versus 0 of 9 of the ETT group suffered PRD. Information about codon analysis was available in 150 patients (58%). Mutated codons were c634 (63%), c618 (19%), c620 (9%), and c804 (6%). Codon-related histologic analysis resulted in prognostic differences: 81% of patients with c634-mutation had MCT or MMTC in contrast to c804 (44%), c618 (34%), and c620 (7%). Fifteen of 17 MMTC and 7 of 9 PRD occurred in patients with c634-mutation. CONCLUSIONS: 1) ETT until 5 years of age in MEN-2A gene carriers results in significant reduction of MTC and MMTC in favor of CCH and improved disease-free long-term outcome. 2) Codon analysis is an important prognostic factor. Timing of TT could be individualized based on codon-specific prognosis. Until more detailed knowledge is available, consequent genetic and biochemical screening is mandatory for appropriate individual timing of ETT before age of 5 years.|*Drosophila Proteins[MESH]|Adolescent[MESH]|Adult[MESH]|Age Factors[MESH]|Carcinoma, Medullary/genetics/pathology/prevention & control/secondary[MESH]|Child[MESH]|Child, Preschool[MESH]|Codon/*genetics[MESH]|Genetic Predisposition to Disease/genetics[MESH]|Humans[MESH]|Hyperparathyroidism/epidemiology/genetics[MESH]|Infant[MESH]|Multiple Endocrine Neoplasia Type 2a/*diagnosis/genetics/pathology/*surgery[MESH]|Multivariate Analysis[MESH]|Neoplasm Recurrence, Local/genetics/pathology/prevention & control[MESH]|Neoplasm Staging[MESH]|Neoplasms, Ductal, Lobular, and Medullary/genetics/pathology/prevention & control[MESH]|Pheochromocytoma/epidemiology/genetics[MESH]|Prognosis[MESH]|Proto-Oncogene Proteins c-ret[MESH]|Proto-Oncogene Proteins/genetics[MESH]|Receptor Protein-Tyrosine Kinases/genetics[MESH]|Thyroid Neoplasms/genetics/pathology/*surgery[MESH]|Thyroidectomy/*methods[MESH]|Treatment Outcome[MESH] |